Some ETFs Saying a Salix Takeover Could be Afoot

Shares of Salix Pharmaceuticals (NasdaqGS: SLXP) are trading higher by 2.6% Friday on volume that is quickly approaching triple the daily average on news that the company is mulling a sale of itself to generic drug maker Actavis (NYSE: ACT). “Though no deal is imminent, an agreement between Salix...